Charles River Laboratories (CRL)
$359.41 -4.44% Close Oct 30, 2026 Live
Charles River Laboratories stock today
Charles River Laboratories closed at $359.41 on October 30, 2026, down 4.44% on the day. Over the past year it returned +100.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $17.3 billion.
$200.00$300.00
NovJan 2026MarMayJulSep
| Period | CRL | S&P 500 (SPY) |
|---|---|---|
| 1 month | +21.8% | -0.9% |
| 3 months | +53.2% | +2.1% |
| Year to date | +80.2% | +11.7% |
| 1 year | +100.7% | +12.4% |
| 3 years | +118.5% | +88.5% |
| 5 years | -19.9% | +76.0% |
Key statistics
- Market value
- $17.3B
- Forward P/E
- 29.8
- Price / sales
- 4.3
- 52-week range
- $149.93 to $376.10
- Next report
- Nov 4, 2026
About Charles River Laboratories
Provides laboratory services, research models, and scientific solutions for drug development and safety testing.
Sector: Health Care · Industry: Life Sciences Tools & Services
More on Charles River Laboratories
- Financials: revenue, earnings and segmentsRevenue -1% in the year to Dec 2025
- Valuation: P/E history and peers
- Returns: what $1,000 became$1,000 ten years ago is $4,729 today
No forecast, no recommendation. This page describes Charles River Laboratories from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.